Close

PureTech Founded Entity Akili Collaborates with Weill Cornell Medicine, NewYork-Presbyterian Hospital and Vanderbilt University Medical Center to Study Digital Therapeutic AKL-T01 as Potential Treatme

Go back to PureTech Founded Entity Akili Collaborates with Weill Cornell Medicine, NewYork-Presbyterian Hospital and Vanderbilt University Medical Center to Study Digital Therapeutic AKL-T01 as Potential Treatme
(NASDAQ: PRTC) Delayed: 26.94 --0 (-0%)
Previous Close $26.94    52 Week High
Open $26.94    52 Week Low
Day High $26.94    P/E N/A 
Day Low $26.94    EPS
Volume 228       

(NASDAQ: PRTC) Delayed: 26.94 --0 (-0%)
Previous Close $26.94    52 Week High
Open $26.94    52 Week Low
Day High $26.94    P/E N/A 
Day Low $26.94    EPS
Volume 228